These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
291 related articles for article (PubMed ID: 11560455)
1. Sustained-release bupropion for pharmacologic relapse prevention after smoking cessation. a randomized, controlled trial. Hays JT; Hurt RD; Rigotti NA; Niaura R; Gonzales D; Durcan MJ; Sachs DP; Wolter TD; Buist AS; Johnston JA; White JD Ann Intern Med; 2001 Sep; 135(6):423-33. PubMed ID: 11560455 [TBL] [Abstract][Full Text] [Related]
2. A comparison of sustained-release bupropion and placebo for smoking cessation. Hurt RD; Sachs DP; Glover ED; Offord KP; Johnston JA; Dale LC; Khayrallah MA; Schroeder DR; Glover PN; Sullivan CR; Croghan IT; Sullivan PM N Engl J Med; 1997 Oct; 337(17):1195-202. PubMed ID: 9337378 [TBL] [Abstract][Full Text] [Related]
3. A double-blind placebo-controlled trial of bupropion sustained-release for smoking cessation in schizophrenia. Evins AE; Cather C; Deckersbach T; Freudenreich O; Culhane MA; Olm-Shipman CM; Henderson DC; Schoenfeld DA; Goff DC; Rigotti NA J Clin Psychopharmacol; 2005 Jun; 25(3):218-25. PubMed ID: 15876899 [TBL] [Abstract][Full Text] [Related]
4. A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia. Evins AE; Cather C; Culhane MA; Birnbaum A; Horowitz J; Hsieh E; Freudenreich O; Henderson DC; Schoenfeld DA; Rigotti NA; Goff DC J Clin Psychopharmacol; 2007 Aug; 27(4):380-6. PubMed ID: 17632223 [TBL] [Abstract][Full Text] [Related]
5. Efficacy of bupropion and predictors of successful outcome in a sample of French smokers: a randomized placebo-controlled trial. Aubin HJ; Lebargy F; Berlin I; Bidaut-Mazel C; Chemali-Hudry J; Lagrue G Addiction; 2004 Sep; 99(9):1206-18. PubMed ID: 15317642 [TBL] [Abstract][Full Text] [Related]